Skip to nav Skip to content


Facebook Twitter LinkedIn Email

IDSA and HIVMA on Updated PrEP Recommendations

The Infectious Diseases Society of America and the HIV Medicine Association welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.

Senate Appropriations Bill Misses Opportunity to Fund Workforce Pilot Program

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

House Appropriations Bills Endanger Domestic and Global ID Programs

IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.

IDSA and HIVMA on Incoming NIAID Director Dr. Jeanne Marrazzo

Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.

Congress Must Sustain HIV Research and Prevention Funding

HIVMA is encouraged by the Senate FY 2024 Labor, Health and Human Services funding bill advanced by the Appropriations Committee, which sustains critical investments in the Ryan White HIV/AIDS Program, the Ending the HIV Epidemic in the U.S. initiative, and the Centers for Disease Control and Prevention’s efforts to establish the foundation for a national PrEP program.

Scientific Advances in HIV Signal Need for Continued Investment

Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.

House LHHS Appropriations Bill Harmful to the HIV Response

House LHHS Appropriations Bill Harmful to the HIV Response HIVMA calls on the Senate to preserve funding for the Ending the HIV Epidemic initiative, Ryan White Program, NIH other essential programs, including PrEP access at the CDC.

IDSA and HIVMA on Preventive Care Ruling

Today’s ruling striking down the preventive services provision of the Affordable Care Act is a major setback to ending HIV as an epidemic and for improving the health of Americans by preventing the spread of other infectious diseases in the United States.

Providers, Advocates Call for New Strategies to Improve Access to HIV Care

A significant number of people with HIV are left out of the health system, and new delivery models are needed to improve their access to needed care, according to a new report released by the HIV Medicine Association.

HIVMA Applauds FDA’s New Blood Donor Guidelines

HIVMA Chair Michelle Cespedes, MD, MS welcomes the release of new draft guidance recommending deferrals based on individual risk assessment rather than a broad exclusion of an entire community.

HIV Care Interventions Crucial to Reducing Life Expectancy Disparities Between White and Black MSM with HIV

The life expectancy  of non-Hispanic Black men who have sex with men  and who acquire HIV is 6.3 years shorter than their White counterparts when receiving status quo HIV care in the United States, according to simulation modeling findings presented at IDWeek.

HIVMA Names Michelle Cespedes, MD, MS, as Chair of its Board of Directors

HIVMA is pleased to announce new Board members and Michelle Cespedes, MD, MS as chair beginning Oct. 24.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.